Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?

BACKGROUND: In late 2012, ivacaftor became available in the UK for people with cystic fibrosis (CF) aged 6 years and over with a G551D mutation. Long-term changes in treatment patterns have not previously been reported. We investigated long-term treatment patterns in people with CF with a G551D muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Granger, Emily, Davies, Gwyneth, Keogh, Ruth H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097695/
https://www.ncbi.nlm.nih.gov/pubmed/34497037
http://dx.doi.org/10.1016/j.jcf.2021.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097695/
https://www.ncbi.nlm.nih.gov/pubmed/34497037
http://dx.doi.org/10.1016/j.jcf.2021.08.014

Ejemplares similares